Literature DB >> 19275632

Active and passive Abeta-immunotherapy: preclinical and clinical studies and future directions: part I.

Michael G Agadjanyan, David H Cribbs.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19275632     DOI： 10.2174/187152709787601849

Source DB:  PubMed          Journal:  CNS Neurol Disord Drug Targets        ISSN： 1871-5273            Impact factor:   4.388


× No keyword cloud information.
  7 in total

1.  Delivery of a DNA vaccine for Alzheimer's disease by electroporation versus gene gun generates potent and similar immune responses.

Authors:  Hayk Davtyan; Anahit Ghochikyan; Nina Movsesyan; Barry Ellefsen; Irina Petrushina; David H Cribbs; Drew Hannaman; Claire F Evans; Michael G Agadjanyan
Journal:  Neurodegener Dis       Date:  2012-02-01       Impact factor: 2.977

2.  Restricted V gene usage and VH/VL pairing of mouse humoral response against the N-terminal immunodominant epitope of the amyloid β peptide.

Authors:  Remy Robert; Marie-Paule Lefranc; Anahit Ghochikyan; Michael G Agadjanyan; David H Cribbs; William E Van Nostrand; Kim L Wark; Olan Dolezal
Journal:  Mol Immunol       Date:  2010 Nov-Dec       Impact factor: 4.407

3.  A dual vaccine against influenza & Alzheimer's disease failed to enhance anti-β-amyloid antibody responses in mice with pre-existing virus specific memory.

Authors:  Hayk Davtyan; Anahit Ghochikyan; Armine Hovakimyan; Arpine Davtyan; Richard Cadagan; Annette M Marleau; Randy A Albrecht; Adolfo García-Sastre; Michael G Agadjanyan
Journal:  J Neuroimmunol       Date:  2014-10-16       Impact factor: 3.478

4.  Comparison of Efficacy of Preventive and Therapeutic Vaccines Targeting the N Terminus of β-Amyloid in an Animal Model of Alzheimer's Disease.

Authors:  Irina Petrushina; Hayk Davtyan; Armine Hovakimyan; Arpine Davtyan; Giselle F Passos; David H Cribbs; Anahit Ghochikyan; Michael G Agadjanyan
Journal:  Mol Ther       Date:  2017-01-04       Impact factor: 11.454

Review 5.  A fresh perspective from immunologists and vaccine researchers: active vaccination strategies to prevent and reverse Alzheimer's disease.

Authors:  Michael G Agadjanyan; Nikolai Petrovsky; Anahit Ghochikyan
Journal:  Alzheimers Dement       Date:  2015-07-17       Impact factor: 21.566

6.  DNA prime-protein boost increased the titer, avidity and persistence of anti-Abeta antibodies in wild-type mice.

Authors:  H Davtyan; M Mkrtichyan; N Movsesyan; I Petrushina; G Mamikonyan; D H Cribbs; M G Agadjanyan; A Ghochikyan
Journal:  Gene Ther       Date:  2009-10-29       Impact factor: 5.250

7.  The immunological potency and therapeutic potential of a prototype dual vaccine against influenza and Alzheimer's disease.

Authors:  Hayk Davtyan; Anahit Ghochikyan; Richard Cadagan; Dmitriy Zamarin; Irina Petrushina; Nina Movsesyan; Luis Martinez-Sobrido; Randy A Albrecht; Adolfo García-Sastre; Michael G Agadjanyan
Journal:  J Transl Med       Date:  2011-08-01       Impact factor: 5.531
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.